Gaithersburg's Novavax inc. gains FDA fast track as it ramps up late-stage RSV vaccine studies - Washington Business Journal

Novavax Inc. has won a potentially lucrative fast-track designation from the U.S. Food and Drug Administration for one of its lead vaccine candidates to protect older patients against a respiratory virus known as RSV.